LCA-Vision Inc. 

(Public, NASDAQ:LCAV)   Watch this stock   
Find more results for LCAV
Feb 9, 2010
Q4 2009 Earnings Conference Call - Webcast
Feb 9, 2010
Q4 2009 Earnings Release
Jan 27, 2010
Jefferies Global Healthcare Services Conference - Webcast
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin -71.99% -3.23%
Operating margin -37.50% -4.01%
EBITD margin - 4.75%
Return on average assets -59.12% -3.94%
Return on average equity -124.18% -7.51%
Employees 476 -

Address

7840 Montgomery Road
Cincinnati, OH 45236
United States - Map
+1-513-7929292 (Phone)
+1-513-7925620 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

LCA-Vision Inc. discussed on blogs

Top Day Trader Alerts (AMGN, ACLI, CTIC, CERS, ERTS, LCAV, NBG, SQNM) - 247admin - Volume Spike Investor - 6 hours ago
LCA-Vision Slumping 9.5% in Pre-Bell Trade – Q4 Revenue Down vs ... - MidnightTrader.com - ONN.tv - 7 hours ago
Pre-Market Earnings (Feb. 9) - editor - Wall Street Pit - 8 hours ago

LCA-Vision Inc. discussions

  View all discussions »

Description

LCA-Vision Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. The Company’s vision centers provide the staff, facilities, equipment and support services for performing laser vision correction procedures that employ laser technologies to help correct nearsightedness, farsightedness and astigmatism. The ophthalmologists perform the laser vision correction procedures in the Company’s vision centers, and either ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-ups in-center. As of December 31, 2008, the Company operated 75 LasikPlus fixed-site laser vision correction centers. It also has a joint venture in Canada. The Company provides primarily two types of procedures in its vision centers: Photorefractive Keratectomy (PRK) and Surface Ablation, and Laser-Assisted In-Situ Keratomileusis (LASIK).

Officers and directors

Michael J. Celebrezze
Chief Financial Officer, Senior Vice President - Finance, Treasurer
Age: 52
Bio & Compensation - Reuters
David L. Thomas
Chief Operating Officer, Senior Vice President - Operations
Age: 50
Bio & Compensation - Reuters
Rhonda S. Sebastian
Senior Vice President - Human Resources
Bio & Compensation - Reuters
E. Anthony Woods
Non-Executive Chairman of the Board
Age: 68
Bio & Compensation - Reuters
John C. Hassan
Director
Age: 66
Bio & Compensation - Reuters
John H. Gutfreund
Director
Age: 79
Bio & Compensation - Reuters
William F. Bahl
Director
Age: 58
Bio & Compensation - Reuters
Edgar F. Heizer III
Director
Age: 49
Bio & Compensation - Reuters